Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03712553 · ClinicalTrials.gov registry record · NA
Behavioral Science and Hepatitis C Screening Outreach
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 21,493
- Enrollment target
NCT03712553: Completed NA study, sponsored by University of Pennsylvania.
NCT03712553 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 21,493 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03712553, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,493 participants
- Enrollment target
Study Summary
This project aims to evaluate different approaches to increase Hepatitis C screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase completion of screening among eligible patients, including changing the default from opt-in to opt-out and incorporating behavioral science principles into the outreach communication.
Interventions
- BEHAVIORAL Letter
- BEHAVIORAL Opt-Out
- BEHAVIORAL Behavioral Economic Messaging
- BEHAVIORAL Usual Care Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,493 participants |
| Start Date | 2019-03-15 |
| Est. Completion | 2020-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03712553
The ClinicalTrials.gov registry entry for NCT03712553 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21,493 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Letter is the first listed.
NCT03712553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03712553 about?
NCT03712553 is a clinical study titled "Behavioral Science and Hepatitis C Screening Outreach". This project aims to evaluate different approaches to increase Hepatitis C screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase completion of screening among eligible patients,...
What is the current status of trial NCT03712553?
This trial is currently completed. It is a NA study. The enrollment target is 21,493 participants. The study started on 2019-03-15. Estimated completion is 2020-10-15.
What interventions are being tested in trial NCT03712553?
The interventions under investigation include: Letter (BEHAVIORAL), Opt-Out (BEHAVIORAL), Behavioral Economic Messaging (BEHAVIORAL), Usual Care Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT03712553?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.